RU2017126027A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2017126027A3 RU2017126027A3 RU2017126027A RU2017126027A RU2017126027A3 RU 2017126027 A3 RU2017126027 A3 RU 2017126027A3 RU 2017126027 A RU2017126027 A RU 2017126027A RU 2017126027 A RU2017126027 A RU 2017126027A RU 2017126027 A3 RU2017126027 A3 RU 2017126027A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014-258383 | 2014-12-22 | ||
| JP2014258383 | 2014-12-22 | ||
| PCT/JP2015/085704 WO2016104441A1 (ja) | 2014-12-22 | 2015-12-21 | 角膜上皮障害治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2017126027A RU2017126027A (ru) | 2019-01-24 |
| RU2017126027A3 true RU2017126027A3 (ru) | 2019-05-17 |
Family
ID=56150460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2017126027A RU2017126027A (ru) | 2014-12-22 | 2015-12-21 | Лекарственное средство для лечения расстройств эпителия роговицы |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20170369494A1 (ru) |
| EP (1) | EP3238723B1 (ru) |
| JP (1) | JP6596022B2 (ru) |
| KR (1) | KR20170095850A (ru) |
| CN (1) | CN107106572B (ru) |
| CA (1) | CA2971380A1 (ru) |
| RU (1) | RU2017126027A (ru) |
| WO (1) | WO2016104441A1 (ru) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2018035075A (ja) * | 2016-08-29 | 2018-03-08 | 株式会社Ｌｔｔバイオファーマ | ドライアイ治療剤 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ526164A (en) * | 2000-12-01 | 2004-09-24 | Ajinomoto Kk | Lactam compounds and pharmaceutical use for treating diabetes |
| CA2566607C (en) * | 2004-05-13 | 2014-04-15 | University Of Virginia Patent Foundation | Use of lacritin in promoting ocular cell survival |
| EP2157092A4 (en) * | 2007-04-11 | 2011-04-13 | Ajinomoto Kk | MEANS FOR THE TREATMENT OF DIABETES |
| WO2008136393A1 (ja) * | 2007-04-27 | 2008-11-13 | Ajinomoto Co., Inc. | ラクタム化合物の結晶形およびその製造方法 |
| WO2008139575A1 (ja) * | 2007-04-27 | 2008-11-20 | Ajinomoto Co., Inc. | 経口投与用製剤 |
-
2015
- 2015-12-21 CN CN201580069933.9A patent/CN107106572B/zh not_active Expired - Fee Related
- 2015-12-21 JP JP2016566356A patent/JP6596022B2/ja active Active
- 2015-12-21 CA CA2971380A patent/CA2971380A1/en not_active Abandoned
- 2015-12-21 US US15/539,015 patent/US20170369494A1/en not_active Abandoned
- 2015-12-21 WO PCT/JP2015/085704 patent/WO2016104441A1/ja active Application Filing
- 2015-12-21 RU RU2017126027A patent/RU2017126027A/ru not_active Application Discontinuation
- 2015-12-21 EP EP15873009.3A patent/EP3238723B1/en active Active
- 2015-12-21 KR KR1020177015927A patent/KR20170095850A/ko unknown
-
2021
- 2021-03-25 US US17/212,707 patent/US20210206773A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP6596022B2 (ja) | 2019-10-23 |
| KR20170095850A (ko) | 2017-08-23 |
| EP3238723B1 (en) | 2020-02-05 |
| EP3238723A4 (en) | 2018-09-05 |
| EP3238723A1 (en) | 2017-11-01 |
| CA2971380A1 (en) | 2016-06-30 |
| CN107106572A (zh) | 2017-08-29 |
| CN107106572B (zh) | 2021-01-12 |
| US20170369494A1 (en) | 2017-12-28 |
| JPWO2016104441A1 (ja) | 2017-10-05 |
| US20210206773A1 (en) | 2021-07-08 |
| WO2016104441A1 (ja) | 2016-06-30 |
| RU2017126027A (ru) | 2019-01-24 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20190828 |